Zhang, Lanxin http://orcid.org/0000-0002-3740-4450
Iannuzzi, Sara http://orcid.org/0009-0003-3704-5931
Chaturvedula, Ayyappa
Irungu, Elizabeth
Haberer, Jessica E.
Hendrix, Craig W.
von Kleist, Max http://orcid.org/0000-0001-6587-6394
Article History
Received: 3 April 2023
Accepted: 26 September 2023
First Online: 13 November 2023
Competing interests
: J.H. has been a consultant for Merck; prior studies have received donated FTC-TDF from Gilead. C.W.H. has received funding for clinical research and been a (past) consultant for Merck, Gilead and ViiV/GSK, holds US patents related to HIV prevention technology (US20200138700A1) and founded Prionde Biopharma, LLC, a microbicide company; all relationships were managed by Johns Hopkins University. The remaining authors declare no competing interests.